DDI’s researchers on #1 show in Kuwait
DDI’s researchers were invited to the #1 show on KTV1 ‘Layali AlKuwait’ to discuss the latest research achievements and findings. Dr. Faisal Al-Refaei, Chief Operating Officer, Dr.
Biochemistry and Molecular Biology Unit are granted a patent
The DDI “Patent and Research Translation Committee” congratulates the researchers on the grant of U.S. patent on our new invention “Use of MicroRNA-103 as Inhibitor for dyslipidemia by repressin
AlQabas-Two COVID-19 strains can merge into a more contagious strain
Times-DDI’s researchers urge policy makers to speed up vaccine process
Alanbaa-Speed up COVID-19 vaccination to prevent from a deadlier COVID-19 strain
DDI joins a research study that explains why COVID-19 effects young adults
AlSeyassah-Scientists warn of the merge of 2 COVID-19 variants
Aljarida-In 2020, we confirmed the possible merge of two COVID-19 variants
DDI’s Latest Research Achievements
DDI receives 8 patents in diabetes research
AlQabas-The latest GeoHealth studies to tackle the diabetes epidemic
Dangers of COVID-19 increase with high blood sugar levels
Why are COVID-19 symptoms severe in young adults ?
Alanbaa-10% of COVID-19 patients w/o chronic diseases have antibodies that attack the immune system
AlQabas-Prof Fahd Almulla explains why COVID-19 effects young adults
AlJarida-DDI participates in a study to determine the cause of COVID-19 severity in young adults
AlQabas-High blood sugar levels increase risk of COVID-19
Severity of COVID-19 increases with high blood glucose levels
It is in our genes!
New research study highlights differences in genetic risk for metabolic disease. In a recently published article in the Human Genetics Journal, Professor Fahd Al Mulla, Chief Scientific O
Dasman Diabetes Institute Honors the Kuwait Fire Service Directorate
The senior management of Dasman Diabetes Institute represented by Dr. Hilal Al-Sayer, Chairman of the Board of Trustees, Dr. Qais Al-Duwairi, Director-General, Dr. Faisal Al-Refaei, Chief Operati